Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Augmedix (AUGX)
NASDAQ:AUGX
Augmedix (AUGX) Stock Price & Analysis
74 Followers
AUGX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.99 - $6.25
Previous Close$1.15
Volume3.00M
Average Volume (3M)552.75K
Market Cap
$57.78M
Enterprise Value$35.70M
Total Cash (Recent Filing)$46.22M
Total Debt (Recent Filing)$25.85M
Price to Earnings (P/E)-2.7
Beta0.59
Next Earnings
Aug 05, 2024EPS Estimate
-$0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.43
Shares Outstanding48,967,729
10 Day Avg. Volume1,737,996
30 Day Avg. Volume552,747
Standard Deviation0.21
R-Squared0.00023
Alpha0.00317
Financial Highlights & Ratios
Price to Book (P/B)4.91
Price to Sales (P/S)4.42
Price to Cash Flow (P/CF)-29.40
P/FCF Ratio9.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.80
Enterprise Value/Gross Profit1.66
Enterprise Value/Ebitda-5.93
Forecast
1Y Price Target
$3.75Price Target Upside217.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
Augmedix News
Bulls Say, Bears Say
Bulls Say
Customer RetentionA significant increase in the dollar-based net revenue retention ratio demonstrates Augmedix's success in upselling and deepening relationships with existing clients.
EarningsAugmedix reported strong growth with revenue up 45% year-over-year and an adjusted EBITDA loss lower than expected, indicating an improving financial health.
Product ExpansionThe trial of Augmedix Go in the emergency room setting with HCA Healthcare and the planned full launch show potential for product expansion and increased market penetration.
Bears Say
Competition And Product DevelopmentManagement acknowledged increased competition and delayed healthcare rollout.
Earnings GuidanceDowngrade to In Line On Lower Growth due to disappointing guidance.
Financial HealthThe company has widened its 2024 EBITDA loss estimate due to a gross margin impact from India and Bangladesh and higher operating expenses, reflecting some financial challenges ahead.
---
Ownership Overview
54.73% Insiders
5.66% Mutual Funds
27.36% Other Institutional Investors
12.25% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AUGX FAQ
What was Augmedix’s price range in the past 12 months?
Augmedix lowest stock price was $0.98 and its highest was $6.25 in the past 12 months.
What is Augmedix’s market cap?
Currently, no data Available
When is Augmedix’s upcoming earnings report date?
Augmedix’s upcoming earnings report date is Aug 05, 2024 which is in 82 days.
How were Augmedix’s earnings last quarter?
Augmedix released its earnings results on May 13, 2024. The company reported -$0.12 earnings per share for the quarter, beating the consensus estimate of -$0.13 by $0.01.
Is Augmedix overvalued?
According to Wall Street analysts Augmedix’s price is currently Undervalued.
Does Augmedix pay dividends?
Augmedix does not currently pay dividends.
What is Augmedix’s EPS estimate?
Augmedix’s EPS estimate is -$0.13.
How many shares outstanding does Augmedix have?
Augmedix has 48,967,728 shares outstanding.
What happened to Augmedix’s price movement after its last earnings report?
Augmedix reported an EPS of -$0.12 in its last earnings report, beating expectations of -$0.13. Following the earnings report the stock price went down -51.282%.
Which hedge fund is a major shareholder of Augmedix?
Among the largest hedge funds holding Augmedix’s share is Ardsley Advisory Partners. It holds Augmedix’s shares valued at 3M.
---
Augmedix Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.75 (217.80% Upside)
$3.75 (217.80% Upside)
Blogger Sentiment
Bullish
AUGX Sentiment 83%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.9%
Last 30 Days ▼ 9.4%
Last 30 Days ▼ 9.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-64.33%
12-Months-Change
Fundamentals
Return on Equity
-280.04%
Trailing 12-Months
Asset Growth
80.11%
Trailing 12-Months
Company Description
Augmedix
Augmedix Inc humanizes the clinician-patient experience by enabling clinicians to focus on what matters most, delivering high-quality patient care. It converts natural clinician-patient conversation into medical documentation and provides real-time administrative support, including referrals, orders, and reminders. The service, which supports over 35 specialties, delivers timely, accurate and comprehensive medical documentation to several of the healthcare systems in the U.S. and to hundreds of independent clinicians nationwide. Augmedix focuses on saving clinicians 2-3 hours per day, improve clinician productivity by as much as 20%, and increase clinicians' satisfaction with work-life balance over 40%.
---
AUGX Earnings Call
Q1 2024
0:00 / 0:00
---
AUGX Stock 12 Month Forecast
Average Price Target
$3.75
▲(217.80% Upside)
Technical Analysis
Best Analysts Covering AUGX
1 Year
1 Year Success Rate
1/7 ratings generated profit
1 Year Average Return
-41.09%
reiterated a buy rating 2 months ago
Copying Bill Sutherland's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -41.09% per trade.
---